957 related articles for article (PubMed ID: 35502787)
1. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
[TBL] [Abstract][Full Text] [Related]
2. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Hsieh SC; Peterson J; Zheng C; Kelly SE; Shea B; Tugwell P
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD003376. PubMed ID: 38591743
[TBL] [Abstract][Full Text] [Related]
3. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells G; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
Cochrane Database Syst Rev; 2008 Jan; (1):CD004523. PubMed ID: 18254053
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for steroid-induced osteoporosis.
Allen CS; Yeung JH; Vandermeer B; Homik J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
[TBL] [Abstract][Full Text] [Related]
7. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
Cochrane Database Syst Rev; 2008 Jan; (1):CD001155. PubMed ID: 18253985
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
9. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003376. PubMed ID: 18254018
[TBL] [Abstract][Full Text] [Related]
10. Calcium and vitamin D for increasing bone mineral density in premenopausal women.
Méndez-Sánchez L; Clark P; Winzenberg TM; Tugwell P; Correa-Burrows P; Costello R
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012664. PubMed ID: 36705288
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Johnston RV; Rischin KJ; Homik J; Jones CA; Golmohammadi K; Kallmes DF
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006349. PubMed ID: 29618171
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Jeffery TC; Chang AB; Conwell LS
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD002010. PubMed ID: 36625789
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Johnston RV; Rischin KJ; Homik J; Jones CA; Golmohammadi K; Kallmes DF
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006349. PubMed ID: 30399208
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906
[TBL] [Abstract][Full Text] [Related]
15. Exercise for improving outcomes after osteoporotic vertebral fracture.
Gibbs JC; MacIntyre NJ; Ponzano M; Templeton JA; Thabane L; Papaioannou A; Giangregorio LM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD008618. PubMed ID: 31273764
[TBL] [Abstract][Full Text] [Related]
16. Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials.
Deardorff WJ; Cenzer I; Nguyen B; Lee SJ
JAMA Intern Med; 2022 Jan; 182(1):33-41. PubMed ID: 34807231
[TBL] [Abstract][Full Text] [Related]
17. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
[TBL] [Abstract][Full Text] [Related]
18. WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney A; Adachi JD; Guyatt G; Papaioannou A; Robinson VA; Shea BJ; Tugwell P; Waldegger LM; Weaver B; Wells G; Zytaruk N
Cochrane Database Syst Rev; 2007 Jul; (1):CD004523. PubMed ID: 17636764
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Golmohammadi K; Johnston RV; Owen RJ; Homik J; Jones A; Dhillon SS; Kallmes DF; Lambert RG
Cochrane Database Syst Rev; 2015 Apr; (4):CD006349. PubMed ID: 25923524
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Avenell A; Mak JC; O'Connell D
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]